These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
270 related items for PubMed ID: 25103500
1. The choice of second-line therapy in steroid-resistant immune thrombocytopenia: role of platelet kinetics in a single-centre long-term study. Palandri F, Polverelli N, Catani L, Sollazzo D, Romano M, Levorato M, Vianelli N. Am J Hematol; 2014 Nov; 89(11):1047-50. PubMed ID: 25103500 [Abstract] [Full Text] [Related]
2. [Prediction of the splenectomy efficacy in chronic immune thrombocytopenic purpura]. Todorović-Tirnanić M, Obradović V, Rolović Z, Suvajdzić N, Elezović I, Colović M, Pavlović S, Bosnjaković V. Glas Srp Akad Nauka Med; 2005 Nov; (48):119-35. PubMed ID: 16405235 [Abstract] [Full Text] [Related]
3. Does the site of platelet sequestration predict the response to splenectomy in adult patients with immune thrombocytopenic purpura? Navez J, Hubert C, Gigot JF, Navez B, Lambert C, Jamar F, Danse E, Lannoy V, Jabbour N. Platelets; 2015 Nov; 26(6):573-6. PubMed ID: 25275667 [Abstract] [Full Text] [Related]
4. Platelet kinetic study in patients with idiopathic thrombocytopenic purpura (ITP) refractory or relapsing after corticosteroid treatment. Rossi G, Cattaneo C, Motta M, Pizzocaro C, Lanzi S, Pouchè A. Hematol J; 2002 Nov; 3(3):148-52. PubMed ID: 12111651 [Abstract] [Full Text] [Related]
5. Autologous 111 In-labelled platelet sequestration studies in patients with primary immune thrombocytopenia (ITP) prior to splenectomy: a report from the United Kingdom ITP Registry. Sarpatwari A, Provan D, Erqou S, Sobnack R, David Tai FW, Newland AC. Br J Haematol; 2010 Dec; 151(5):477-87. PubMed ID: 20950403 [Abstract] [Full Text] [Related]
6. [Initial 111In-platelet kinetics: indicator of platelet sequestration/destruction site or quality control of platelet labelling?]. Todorović-Tirnanić M, Obradović V, Rolović Z, Suvajdzić N, Elezović I, Colović M, Pavlović S, Starcević V, Bosnjaković V. Glas Srp Akad Nauka Med; 2005 Dec; (48):101-18. PubMed ID: 16405234 [Abstract] [Full Text] [Related]
7. Overview of 321 patients with idiopathic thrombocytopenic purpura. Retrospective analysis of the clinical features and response to therapy. Pamuk GE, Pamuk ON, Başlar Z, Ongören S, Soysal T, Ferhanoğlu B, Aydin Y, Ulkü B, Aktuğlu G, Akman N. Ann Hematol; 2002 Aug; 81(8):436-40. PubMed ID: 12224000 [Abstract] [Full Text] [Related]
8. Durability and factors associated with long term response after splenectomy for primary immune thrombocytopenia (ITP) and outcome of relapsed or refractory patients. Aleem A. Platelets; 2011 Aug; 22(1):1-7. PubMed ID: 20964585 [Abstract] [Full Text] [Related]
9. Long-term efficacy of partial splenic embolization for the treatment of steroid-resistant chronic immune thrombocytopenia. Togasaki E, Shimizu N, Nagao Y, Kawajiri-Manako C, Shimizu R, Oshima-Hasegawa N, Muto T, Tsukamoto S, Mitsukawa S, Takeda Y, Mimura N, Ohwada C, Takeuchi M, Sakaida E, Iseki T, Yoshitomi H, Ohtsuka M, Miyazaki M, Nakaseko C. Ann Hematol; 2018 Apr; 97(4):655-662. PubMed ID: 29332223 [Abstract] [Full Text] [Related]
10. Efficacy and safety of splenectomy in immune thrombocytopenic purpura: long-term results of 402 cases. Vianelli N, Galli M, de Vivo A, Intermesoli T, Giannini B, Mazzucconi MG, Barbui T, Tura S, Baccaranion M, Gruppo Italiano per lo Studio delle Malattie Ematologiche dell'Adulto. Haematologica; 2005 Jan; 90(1):72-7. PubMed ID: 15642672 [Abstract] [Full Text] [Related]
11. Long-term follow-up analysis after rituximab salvage therapy in adult patients with immune thrombocytopenia. Zaja F, Volpetti S, Chiozzotto M, Puglisi S, Isola M, Buttignol S, Fanin R. Am J Hematol; 2012 Sep; 87(9):886-9. PubMed ID: 22718483 [Abstract] [Full Text] [Related]
12. Efficacy and safety of splenectomy in adult chronic immune thrombocytopenia. Zoghlami-Rintelen C, Weltermann A, Bittermann C, Kyrle PA, Pabinger I, Lechner K, Wenzl E. Ann Hematol; 2003 May; 82(5):290-4. PubMed ID: 12739064 [Abstract] [Full Text] [Related]
14. [Treatment outcome of immune thrombocytopenia]. Iványi JL, Marton E, Plander M. Orv Hetil; 2012 Oct 14; 153(41):1613-21. PubMed ID: 23045311 [Abstract] [Full Text] [Related]
15. Treatment of idiopathic thrombocytopenic purpura (ITP) in patients with refractoriness to or with contraindication for corticosteroids and/or splenectomy with immunosuppressive therapy and danazol. Schiavotto C, Castaman G, Rodeghiero F. Haematologica; 1993 Oct 14; 78(6 Suppl 2):29-34. PubMed ID: 8039755 [Abstract] [Full Text] [Related]
16. Current management of adult idiopathic thrombocytopenic purpura in practice: a cohort study of 201 patients from a single center. Zimmer J, Andrès E, Noel E, Koumarianou A, Blicklé JF, Maloisel F. Clin Lab Haematol; 2004 Apr 14; 26(2):137-42. PubMed ID: 15053808 [Abstract] [Full Text] [Related]
17. Predictive value of response to steroid therapy on response to splenectomy in children with immune thrombocytopenic purpura. Hollander LL, Leys CM, Weil BR, Rescorla FJ. Surgery; 2011 Oct 14; 150(4):643-8. PubMed ID: 22000175 [Abstract] [Full Text] [Related]
19. Dapsone salvage therapy for adult patients with immune thrombocytopenia relapsed or refractory to steroid and rituximab. Zaja F, Marin L, Chiozzotto M, Puglisi S, Volpetti S, Fanin R. Am J Hematol; 2012 Mar 14; 87(3):321-3. PubMed ID: 22190262 [Abstract] [Full Text] [Related]
20. Laparoscopic splenectomy for immune thrombocytopenic purpura at a teaching institution. Zheng CX, Zheng D, Chen LH, Yu JF, Wu ZM. Chin Med J (Engl); 2011 Apr 14; 124(8):1175-80. PubMed ID: 21542991 [Abstract] [Full Text] [Related] Page: [Next] [New Search]